Sol-Gel Technologies (SLGL) Net Margin (2018 - 2026)
Sol-Gel Technologies (SLGL) recorded Net Margin of -622.84% in Q2 2026, down 690.10 percentage points from 67.26% a year earlier and down 4073.77 percentage points from the prior quarter.
Powered by 
Analysis
Sol-Gel Technologies (SLGL) Net Margin (2018 - 2026) Analysis & Trends
On a TTM basis, Sol-Gel Technologies' Net Margin came in at -494.87% as of Jun 30, 2026, down 554.24 percentage points year-over-year; for FY2025, it came in at -31.60%, up 60.09 percentage points from FY2024.
- Annual Net Margin has a five-year change of +302.34 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at -91.70% in FY2024 (+1661.07 pp), -1752.77% in FY2023 (-1368.45 pp), -384.32% in FY2022 (-397.87 pp) and 13.55% in FY2021 (+347.49 pp).
- Quarterly Net Margin has ranged from -5785.00% in Q4 2022 to 186566.67% in Q1 2022 over the past five years.
- On a year-over-year basis, Net Margin rose in four of the last eight quarters, with an average year-over-year change of +409.85 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 185987.07 percentage points in Q1 2022, against a drop of 182993.00 percentage points in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 3450.93% (Q1 2026), -429.17% (Q4 2025) and -1485.50% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Sol-Gel Technologies | 193.50 Mn | 47.91 Mn | - | -622.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -622.84% |
| Mar 31, 2026 | 3,450.93% |
| Dec 31, 2025 | -429.17% |
| Sep 30, 2025 | -1,485.50% |
| Jun 30, 2025 | 67.26% |
| Mar 31, 2025 | 854.32% |
| Dec 31, 2024 | -2,102.88% |
| Sep 30, 2024 | -6.83% |
| Jun 30, 2024 | 36.37% |
| Mar 31, 2024 | 1,361.37% |
| Dec 31, 2023 | -1,081.88% |
| Sep 30, 2023 | -2,681.22% |
| Jun 30, 2023 | -1,005.05% |
| Mar 31, 2023 | 3,573.67% |
| Dec 31, 2022 | -5,785.00% |
| Sep 30, 2022 | -1,305.36% |
| Jun 30, 2022 | 3.81% |
| Mar 31, 2022 | 186,566.67% |
| Dec 31, 2021 | 67.43% |
| Sep 30, 2021 | 96.26% |
API Access
Sol-Gel Technologies Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=SLGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "SLGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=SLGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();